HSBC Analysts Give Compugroup Medical (COP) a €60.00 Price Target

HSBC set a €60.00 ($69.77) price objective on Compugroup Medical (ETR:COP) in a research report sent to investors on Tuesday morning. The brokerage currently has a buy rating on the stock.

COP has been the topic of a number of other research reports. Hauck & Aufhaeuser set a €36.00 ($41.86) target price on shares of Compugroup Medical and gave the company a sell rating in a research note on Wednesday, October 10th. Commerzbank set a €53.00 ($61.63) target price on shares of Compugroup Medical and gave the company a buy rating in a research note on Tuesday, September 11th. Warburg Research set a €53.50 ($62.21) target price on shares of Compugroup Medical and gave the company a buy rating in a research note on Friday, August 10th. Berenberg Bank set a €49.00 ($56.98) target price on shares of Compugroup Medical and gave the company a neutral rating in a research note on Monday, August 13th. Finally, Deutsche Bank set a €62.00 ($72.09) target price on shares of Compugroup Medical and gave the company a buy rating in a research note on Monday, October 22nd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of Hold and an average target price of €51.79 ($60.22).

Shares of COP stock opened at €49.14 ($57.14) on Tuesday. Compugroup Medical has a 52 week low of €40.10 ($46.63) and a 52 week high of €60.30 ($70.12).

About Compugroup Medical

CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.

Read More: Buyback For Investors Defined

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply